{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Horsham",
      "address_1": "425 Privet Rd",
      "reason_for_recall": "CGMP Deviations",
      "address_2": "",
      "product_quantity": "1,299 bags",
      "code_info": "All lots within Expiry. Lot # 4720915, 6790315, 6800315, 6810315, 6820315",
      "center_classification_date": "20160907",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "state": "PA",
      "product_description": "ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-0020-31 (Single Use Bag), NDC # 0703-0020-32 (5 Single Use Bags in One Carton).",
      "report_date": "20160914",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Teva North America",
      "recall_number": "D-1494-2016",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "74497",
      "termination_date": "20170207",
      "more_code_info": "",
      "recall_initiation_date": "20160617",
      "postal_code": "19044-1220",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}